E-Z-EM, Inc. Announces Financial Results and Conference Call Dates for Second Quarter Fiscal 2006.LAKE SUCCESS, N.Y. -- E-Z-EM, Inc. (Nasdaq:EZEM) today announced that the company will release financial results for the second quarter of fiscal 2006 ended December 3, 2005 after market close on Tuesday, January 10, 2006. Anthony A. Lombardo, president and chief executive officer, and Dennis J. Curtin, chief financial officer, will host an investment conference call beginning at 4:30 p.m. Eastern Time on Tuesday, January 10, 2006 to discuss these results and to answer questions. To participate, please dial (877) 815-7177 from the U.S. or (706) 679-0753 from outside the U.S. In addition, a telephone replay of the call will be accessible for a limited time following completion of the call by dialing (800) 642-1687 or (706) 645-9291 and entering reservation number 3986626. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of E-Z-EM's web site at www.ezem.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software. A replay will be available on the Web site for a limited time. About E-Z-EM, Inc. E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal radiology. The Company recently introduced VoLumen(R) the next generation low density barium sulfate suspension Barium sulfate suspension is barium sulfate (powder) turned into a liquid form by suspending it in a quick-flowing drink to aid in CT scans of the gastrointestinal region. Use for use as an oral contrast in Multidetector CT (MDCT MDCT Modified Discrete Cosine Transform MDCT Multi-detector Computed Tomography MDCT Multiple Description Correlating Transform MDCT Motorsport Dual Clutch Transmission ) and PET/CT PET/CT Positron Emission Tomography and Computed Tomography studies. The Company also offers Empower(R)--the only family of CT injectors on the market with patented EDA(TM) technology that can help detect contrast extravasation--and offers a complete product set for the virtual colonoscopy practitioner. This product line consists of virtual colonoscopy hardware, software, nutritional prep kits and bowel cleaners, tagging agents and a carbon dioxide colon insufflation insufflation /in·suf·fla·tion/ (-sah-fla´shun) 1. the act of blowing a powder, vapor, or gas into a body cavity. 2. finely powdered or liquid drugs carried into the respiratory passages by such devices as aerosols. system. The Company is also the exclusive global manufacturer and marketer of Reactive Skin Decontamination decontamination /de·con·tam·i·na·tion/ (de?kon-tam-i-na´shun) the freeing of a person or object of some contaminating substance, e.g., war gas, radioactive material, etc. de·con·tam·i·na·tion n. Lotion (RSDL (Reverse Spiral Dual Layer) A technique used with dual-layer DVD discs that allows the end of the first layer to seamlessly connect to the second layer. The first layer is recorded from the inside out, and the second layer is recorded from the outside in. ) for first-responder organizations and military services in many countries. RSDL is a liquid skin decontaminant that breaks down chemical agents such as Sarin sarin (zärēn`), volatile liquid used as a nerve gas. It boils at 147°C; but evaporates quickly at room temperature; its vapor is colorless and odorless. or VX in seconds, leaving a non-toxic liquid that can be washed away with water. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion